Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronpass vs Erdos for Acute Bronchitis Symptoms
NCT06038084Phase 4Completed
- Start
- Apr 2022
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Bronpass in acute bronchitis (2 arms). Primary endpoint: Change in Bronchitis Severity Score total score at Day 7. Started Apr 2022; status: completed.
02
Drugs
Bronpass
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on NCT06038084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06038084.